Skip to main content
Premium Trial:

Request an Annual Quote

GSK Licenses Jubilant s Pathway Database

NEW YORK, Jan. 25 (GenomeWeb News) - Glaxo SmithKline has licensed Jubilant Biosys' pathway database, Jubilant of Bangalore, India, said today.


Under the global license, Glaxo plans to use the database, PathArt, for its drug discovery research.


PathArt contains more than 1,200 signal-, metabolic-, and disease-specific pathways that have been manually curated. These pathways cover a number of diseases, including different types of cancer, arthritis, Alzheimer's disease, asthma, multiple sclerosis, Parkinson's disease, diabetes, and atherosclerosis.